Quick Takeaways
- Nantahala Capital Partners Limited Partnership filed SCHEDULE 13G for Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI).
- Disclosed ownership: 5.9%.
- Date of event: 02 Dec 2024.
Nantahala Capital Partners Limited Partnership - 02 Dec 2024 SCHEDULE 13G Report for Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI)
- Filing Manager
- Nantahala Capital Partners Limited Partnership
- Reporting Manager
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
- Symbol
- SNTI
- Shares outstanding
- 5,098,072 shares
- Disclosed Ownership
- 301,500 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 16:31:07 UTC
- Date of event
- 02 Dec 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Partners Limited Partnership disclosed 5.9% ownership in Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI) on 02 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 5.9% | 301,500 | 0 | 301,500 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer Nantahala Capital Management, LLC |